1.
                                                                 
             UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                         WASHINGTON, D.C. 20549
                                FORM 10-Q
                             (AMENDMENT 1)
                                
   X        QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                  OF THE SECURITIES EXCHANGE ACT OF 1934

             For the quarterly period ended October 2, 1994

                                  OR
                                
           TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
               OF THE SECURITIES EXCHANGE ACT OF 1934

            For the transition period from________to_______
                                
                     COMMISSION FILE NUMBER 1-3619
                                 
                                  --
                                
                             PFIZER INC.
          (Exact name of registrant as specified in its charter)

              DELAWARE                            13-5315170
      (State or other jurisdiction of          (I.R.S. Employer
      incorporation or organization)         Identification No.)

              235 East 42nd Street, New York, New York 10017
         (Address of principal executive offices, including zip code)

                           (212) 573-2323
             (Registrant's telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities Exchange Act 
of 1934 during the preceding 12 months (or for such shorter period that 
registrant was required to file such reports) and (2) has been subject to 
such filing requirements for the past 90 days.

YES    X           NO          

Indicate the number of shares outstanding of each of the issuer's classes of 
common stock, as of the latest practicable date.

At October 31, 1994, there were 314,778,431 shares, par value $.10, of the 
issuer's common stock outstanding.

Reason for Filing Form 10-Q (Amendment 1)
Form 10-Q Amendment 1 is being filed for the third quarter of 1994 for 
Pfizer Inc. because when Form 10-Q was filed on November 15, 1994, 
Exhibit 27 was not submitted in the proper format.


						                                                             					2.

										



Item 6:   Exhibits and Reports on Form 8-K

     (a)  Exhibits

          1) Exhibit 11 - Computation of Earnings Per Common Share 
             (previously filed 11/15/94)
          2) Exhibit 12 - Computation of Ratio of Earnings to Fixed Charges 
             (previously filed 11/15/94)
          3) Exhibit 15 - Accountants' Acknowledgement 
             (previously filed 11/15/94)
          4)	Exhibit 27 - Financial Data Schedule

     (b)  No reports on Form 8-K have been filed by the Company during the 
          third quarter ended October 	2, 1994.
                                

                                
                                

                                                            											3.   
                                
                     PFIZER INC. AND SUBSIDIARY COMPANIES
                                
                                
                                
                                   SIGNATURES







Pursuant to the requirements of the Securities Exchange Act of 1934, the 
registrant has duly caused this report to be signed on its behalf by the 
undersigned thereto duly authorized.





                                        							     Pfizer Inc.		
                                       							     (Registrant)



Date:  December 21, 1994										
                               						        H. V. Ryan; Controller
                                  						(Principal Accounting Officer and
                                 						      Duly Authorized Officer)